Press Releases
INOVIO Adds Thermo Fisher Scientific To Global Manufacturing Consortium
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, announced that Thermo Fisher Scientific, the world leader in serving science, has signed a letter of...
Drug Research
PharmAbcine signs a CMO contract with Binex so Binex can produce olinvacimab at its new 5,000L production line
PharmAbcine, a biotech company focusing on the development of antibody therapeutics, announced on August 31 that it had signed a contract manufacturing organization(CMO) agreement with Binex, a leading biologics CDMO(Contract Development and Manufacturing Organization) company in Korea.
With the new...
Drug Research
Catalent and Exelixis Enter into Collaboration, License, and Exclusive Option Agreement to Develop ADC Leveraging SMARTag Bioconjugation Technology
Exelixis, Inc. and Catalent announced a partnership under which Catalent’s Redwood Bioscience subsidiary will develop multiple antibody-drug conjugates (ADCs) for Exelixis using Catalent’s proprietary SMARTag® site-specific bioconjugation technology.
Under the terms of the agreement, Catalent will use its SMARTag® bioconjugation...
Clinical Trials
Sharp launches Clinventory Inventory Management System (IMS) for clinical trials
Sharp - part of UDG Healthcare plc, a global leader in contract packaging clinical supply services, has launched a new Inventory Management System (IMS) to support clinical trial sponsors in managing inventory and supplies.
The new system - named Clinventory...
Drug Research
Enesi Pharma partners with Adelaide University for Zika vaccine
Enesi Pharma, an innovative biotechnology company developing next-generation vaccination products targeting serious diseases, is delighted to announce its partnership with the University of Adelaide to develop a new thermostable, solid dose DNA vaccine for Zika virus to prevent infection...
Press Releases
AbbVie and I-Mab Enter Into Global Strategic Partnership for Differentiated Immuno-oncology Therapy
AbbVie and I-Mab announced that AbbVie and I-Mab have signed a broad, global collaboration agreement for the development and commercialization of lemzoparlimab (also known as TJC4), an innovative anti-CD47 monoclonal antibody internally discovered and developed by I-Mab for the...
Press Releases
KORSCH Introduces Next-Generation Mid-Range Tablet Press
X 3 Tablet Press incorporates production capabilities and versatility traditionally limited to large-scale production machines
State-of-the-art-tableting technology meets the midrange segment at last. The days of having to compromise are over. KORSCH is introducing a groundbreaking mid-range tablet press incorporating...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.